Stadlbauer V. Immunosuppression and probiotics: are they effective and safe? Benef Microbes. 2015;6:823–8.

Article  CAS  PubMed  Google Scholar 

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.

Article  PubMed  Google Scholar 

Rijkers GT, de Vos WM, Brummer RJ, Morelli L, Corthier G, Marteau P. Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr. 2011;106:1291–6.

Article  CAS  PubMed  Google Scholar 

Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. PLoS One. 2018;13:e0209205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jankiewicz M, Łukasik J, Kotowska M, Kołodziej M, Szajewska H. Strain-specificity of Probiotics in Pediatrics: a Rapid Review of the clinical evidence. J Pediatr Gastroenterol Nutr. 2023;76:227–31.

Article  PubMed  Google Scholar 

Bron PA, Tomita S, Mercenier A, Kleerebezem M. Cell surface-associated compounds of probiotic lactobacilli sustain the strain-specificity dogma. Curr Opin Microbiol. 2013;16:262–9.

Article  CAS  PubMed  Google Scholar 

Batista VL, da Silva TF, de Jesus LCL, Coelho-Rocha ND, Barroso FAL, Tavares LM, et al. Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis. Front Microbiol. 2020;11:11.

Article  Google Scholar 

Zhao Z, Xu S, Zhang W, Wu D, Yang G. Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel Disease applications. Food Funct. 2022;13:5914–24.

Article  CAS  PubMed  Google Scholar 

Nißle A. Ueber die Grundlagen Einer Neuen ursächlichen Bekämpfung Der Pathologischen Darmflora. DMW - Deutsche Medizinische Wochenschrift. 1916;42:1181–4.

Article  Google Scholar 

Wassenaar TM. Insights from 100 years of Research with Probiotic E. Coli. Eur J Microbiol Immunol (Bp). 2016;6:147–61.

Article  PubMed  Google Scholar 

Nißle A. Die antagonistische Behandlung Chronischer Darmstörungen Mit Colibakterien. Med Klin. 1918;2:29–33.

Google Scholar 

Sonnenborn U. Escherichia coli strain Nissle 1917—from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties. FEMS Microbiol Lett. 2016;363:fnw212.

Article  PubMed  Google Scholar 

Mohsin M, Guenther S, Schierack P, Tedin K, Wieler LH. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli. Int J Med Microbiol. 2015;305:20–6.

Article  CAS  PubMed  Google Scholar 

Pradhan S, Weiss AA. Probiotic properties of Escherichia coli Nissle in Human Intestinal Organoids. mBio. 2020;11:e01470.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behrouzi A, Mazaheri H, Falsafi S, Tavassol ZH, Moshiri A, Siadat SD. Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. J Diabetes Metab Disord. 2020;19:597–604.

Article  PubMed  PubMed Central  Google Scholar 

Hare PJ, Englander HE, Mok WWK. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. J Appl Microbiol. 2022;132:4020–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olbertz D, Proquitté H, Patzer L, Erler T, Mikolajczak A, Sadowska-Krawczenko I, et al. Potential Benefit of Probiotic E. Coli Nissle in Term neonates. Klin Padiatr. 2022. https://doi.org/10.1055/a-1970-4340.

Article  PubMed  PubMed Central  Google Scholar 

Teng G, Liu Z, Liu Y, Wu T, Dai Y, Wang H, et al. Probiotic Escherichia coli Nissle 1917 expressing elafin protects against inflammation and restores the gut microbiota. Front Microbiol. 2022;13:819336.

Article  PubMed  PubMed Central  Google Scholar 

Chiang CJ, Chao YP, Ali A, Day CH, Ho TJ, Wang PN, et al. Probiotic Escherichia coli Nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced Diabetes in rats. Benef Microbes. 2021;12:283–93.

Article  CAS  PubMed  Google Scholar 

Faghihi AH, Agah S, Masoudi M, Ghafoori SMS, Eshraghi A. Efficacy of Probiotic Escherichia coli Nissle 1917 in patients with irritable bowel syndrome: a double blind placebo-controlled Randomized Trial. Acta Med Indones. 2015;47:201–8.

PubMed  Google Scholar 

Cress BF, Linhardt RJ, Koffas MAG. Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc. 2013;1:e0004713.

Article  PubMed  Google Scholar 

Reister M, Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S, et al. Complete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917. J Biotechnol. 2014;187:106–7.

Article  CAS  PubMed  Google Scholar 

Homburg S, Oswald E, Hacker J, Dobrindt U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 2007;275:255–62.

Article  CAS  PubMed  Google Scholar 

Morgan RN, Saleh SE, Farrag HA, Aboulwafa MM. Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (cnf 1) in Escherichia coli: experimental and bioinformatics analyses. Gut Pathog. 2019;11:22.

Article  PubMed  PubMed Central  Google Scholar 

Olier M, Marcq I, Salvador-Cartier C, Secher T, Dobrindt U, Boury M, et al. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes. 2012;3:501–9.

Article  PubMed  PubMed Central  Google Scholar 

Massip C, Branchu P, Bossuet-Greif N, Chagneau CV, Gaillard D, Martin P, et al. Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917. PLoS Pathog. 2019;15:e1008029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, et al. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome. 2018;6:121.

Article  PubMed  PubMed Central  Google Scholar 

Forsythe P, Bienenstock J. Immunomodulation by commensal and probiotic Bacteria. Immunol Invest. 2010;39:429–48.

Article  CAS  PubMed  Google Scholar 

Anjana, Tiwari SK. Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota. Front Cell Infect Microbiol. 2022;12:851140.

Mills JP, Rao K, Young VB. Probiotics for prevention of Clostridium difficile Infection. Curr Opin Gastroenterol. 2018;34:3–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ventura M, O’Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, van Sinderen D, et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol. 2009;7:61–71.

Article  CAS  PubMed  Google Scholar 

de Melo Pereira GV, de Oliveira Coelho B, Magalhães Júnior AI, Thomaz-Soccol V, Soccol CR. How to select a probiotic? A review and update of methods and criteria. Biotechnol Adv. 2018;36:2060–76.

Article  PubMed  Google Scholar 

Castro-López C, García HS, Guadalupe Martínez-Ávila GC, González-Córdova AF, Vallejo-Cordoba B, Hernández-Mendoza A. Genomics-based approaches to identify and predict the health-promoting and safety activities of promising probiotic strains – A probiogenomics review. Trends Food Sci Technol. 2021;108:148–63.

Article  Google Scholar 

Ventura M, Turroni F, van Sinderen D. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioengineered. 2012;3:73–9.

Article  Google Scholar 

Carvalho RDO, Guédon E, Aburjaile FF, Azevedo V. Editorial: Probiogenomics of classic and next-generation probiotics. Front Microbiol. 2022;13:982642.

Article  PubMed  PubMed Central  Google Scholar 

Tomas J, Reygner J, Mayeur C, Ducroc R, Bouet S, Bridonneau C, et al. Early colonizing Escherichia coli elicits remodeling of rat colonic epithelium shifting toward a new homeostatic state. ISME J. 2015;9:46–58.

Article  CAS  PubMed  Google Scholar 

Escribano-Vazquez U, Verstraeten S, Martin R, Chain F, Langella P, Thomas M, et al. The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic Colitis mouse model. Sci Rep. 2019;9:11431.

Article  PubMed  PubMed Central  Google Scholar 

Bay DC, Rommens KL, Turner RJ. Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim Biophys Acta. 2008;1778:1814–38.

Article  CAS  PubMed  Google Scholar 

Varani AM, Siguier P, Gourbeyre E, Charneau V, Chandler M. ISsaga is an ensemble of web-based methods for high throughput identification and semi-automatic annotation of insertion sequences in prokaryotic genomes. Genome Biol. 2011;12:R30.